M. Fatih Okcu
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 45
-
- Sarcoma Diagnosis and Treatment 22
- Brain Metastases and Treatment 16
- Cancer-related cognitive impairment studies 12
- Radiation Therapy and Dosimetry 11
-
- Childhood Cancer Survivors' Quality of Life 40
- Neurology top 2%
- Neuroblastoma Research and Treatments 13
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 29
- Co-authors
- Arnold C. PaulinoMurali ChintagumpalaMichael E. ScheurerDavid R. GrosshansAnita MahajanLisa S. KahalleyJed G. NuchternMelissa L. Bondy
- Partner nations
- United StatesCanadaTürkiye
In The Last Decade
M. Fatih Okcu
139 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 125
- Genetics 1.2k
- Pulmonary and Respiratory Medicine 1.6k
- Pediatrics, Perinatology and Child Health 871
- Neurology 546
- Oncology 723
Countries citing papers authored by M. Fatih Okcu
This map shows the geographic impact of M. Fatih Okcu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fatih Okcu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fatih Okcu more than expected).
Fields of papers citing papers by M. Fatih Okcu
This network shows the impact of papers produced by M. Fatih Okcu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fatih Okcu. The network helps show where M. Fatih Okcu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Fatih Okcu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 15 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 24 | |
| 14 | 2019 | 13 | |
| 15 | 2017 | 2 | |
| 16 | 2015 | 9 | |
| 17 | 2014 | 40 | |
| 18 | 2013 | 28 | |
| 19 | 2010 | 11 | |
| 20 | 2009 | 79 |
About M. Fatih Okcu
M. Fatih Okcu is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 148 papers that have together received 3.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (45 papers), Childhood Cancer Survivors' Quality of Life (40 papers), Acute Lymphoblastic Leukemia research (29 papers), Sarcoma Diagnosis and Treatment (22 papers), Brain Metastases and Treatment (16 papers), Neuroblastoma Research and Treatments (13 papers), Cancer-related cognitive impairment studies (12 papers) and Radiation Therapy and Dosimetry (11 papers). The work is most often cited by research in Genetics (1.2k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Pediatrics, Perinatology and Child Health (871 citations). M. Fatih Okcu has collaborated with scholars based in United States, Canada and Türkiye. Frequent co-authors include Arnold C. Paulino, Murali Chintagumpala, Michael E. Scheurer, David R. Grosshans, Anita Mahajan, Lisa S. Kahalley, Jed G. Nuchtern, Melissa L. Bondy, Heidi V. Russell and John Hicks. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.